Stay updated with breaking news from 46433010. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanford C. Bernstein started coverage on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Get Rating) in a research note published on Tuesday, The Fly reports. The brokerage issued an underperform rating and a $31.00 target price on the stock. IONS has been the subject of a number of other reports. Barclays lowered their price target on […]
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) has received a consensus rating of “Hold” from the thirteen brokerages that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating on the company. The average […]
Wipfli Financial Advisors LLC purchased a new stake in shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 619 shares of the company’s stock, valued at approximately $27,000. A number of other hedge funds and other […]
US Bancorp DE reduced its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) by 19.3% during the 2nd quarter, HoldingsChannel reports. The institutional investor owned 17,323 shares of the company’s stock after selling 4,135 shares during the quarter. US Bancorp DE’s holdings in Ionis Pharmaceuticals were worth $641,000 at the end of the most […]
Shares of Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Rating) have been given a consensus recommendation of “Hold” by the thirteen ratings firms that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and seven have assigned a buy rating to the […]